- Home
- NKSH vs SGHT Comparison
NKSH vs SGHT Comparison
Compare NKSH & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- SGHT
- Stock Information
- Founded
- NKSH 1891
- SGHT 2011
- Country
- NKSH United States
- SGHT United States
- Employees
- NKSH N/A
- SGHT N/A
- Industry
- NKSH Major Banks
- SGHT Medical Specialities
- Sector
- NKSH Finance
- SGHT Health Care
- Exchange
- NKSH Nasdaq
- SGHT Nasdaq
- Market Cap
- NKSH 162.0M
- SGHT 157.7M
- IPO Year
- NKSH N/A
- SGHT 2021
- Fundamental
- Price
- NKSH $26.14
- SGHT $3.03
- Analyst Decision
- NKSH Strong Buy
- SGHT Buy
- Analyst Count
- NKSH 1
- SGHT 7
- Target Price
- NKSH $38.00
- SGHT $3.92
- AVG Volume (30 Days)
- NKSH 11.4K
- SGHT 163.5K
- Earning Date
- NKSH 05-19-2025
- SGHT 05-08-2025
- Dividend Yield
- NKSH 5.77%
- SGHT N/A
- EPS Growth
- NKSH N/A
- SGHT N/A
- EPS
- NKSH 1.38
- SGHT N/A
- Revenue
- NKSH $46,211,000.00
- SGHT $78,109,000.00
- Revenue This Year
- NKSH $1.17
- SGHT N/A
- Revenue Next Year
- NKSH $9.78
- SGHT $11.17
- P/E Ratio
- NKSH $18.90
- SGHT N/A
- Revenue Growth
- NKSH 2.21
- SGHT N/A
- 52 Week Low
- NKSH $23.75
- SGHT $2.03
- 52 Week High
- NKSH $33.37
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- NKSH 52.22
- SGHT 56.13
- Support Level
- NKSH $25.16
- SGHT $2.81
- Resistance Level
- NKSH $26.83
- SGHT $3.26
- Average True Range (ATR)
- NKSH 0.81
- SGHT 0.24
- MACD
- NKSH 0.14
- SGHT -0.01
- Stochastic Oscillator
- NKSH 60.32
- SGHT 38.57
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.